Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:ALLE
NYSE:ALLEBuilding

Assessing Allegion (ALLE) Valuation After Recent Share Price Strength And Mixed Fair Value Signals

Why Allegion Stock Is On Investors’ Radar Today Allegion (ALLE) has drawn fresh attention after recent share moves, with the stock up 1.8% over the past week and about 3.2% over the past month, despite a roughly 3.1% decline in the past 3 months. See our latest analysis for Allegion. Looking beyond the latest move, Allegion’s share price has a 1-year total shareholder return of 27.24% and a 3-year total shareholder return of 53.00%, while shorter term share price momentum has cooled slightly...
NYSE:ZETA
NYSE:ZETASoftware

Assessing Zeta Global Holdings (ZETA) Valuation As Revenue Grows But Losses Persist

Why Zeta Global Holdings (ZETA) is on investors’ radar Zeta Global Holdings (ZETA) has drawn attention recently as investors weigh its share price of US$20.45 against its current fundamentals. These include annual revenue of US$1.22b and a reported net loss of US$22.81 million. See our latest analysis for Zeta Global Holdings. Recent trading has been choppy, with a 2.20% 1 day share price return and an 8.25% 7 day share price decline. However, a 30 day share price return of 11.63% and a 90...
NYSE:VNO
NYSE:VNOOffice REITs

Paramount Lease Recasts Vornado Realty Trust With New York Studio Exposure

Paramount Television Studios has signed the first lease at Sunset Pier 94 Studios, Vornado Realty Trust's new film and television complex in Manhattan. The agreement marks a key step toward opening Manhattan's first purpose built production facility and advancing the site's role in local community development. For investors watching Vornado Realty Trust (NYSE:VNO), the Paramount lease puts fresh attention on a company better known for its office and retail footprint. Shares closed at...
XTRA:DBK
XTRA:DBKCapital Markets

Deutsche Bank Flags Weaponized Capital Flows And Repositions Funding Strategy

Deutsche Bank executives and strategists have warned that rising US–European trade tensions are increasingly tied to the use of capital flows as political leverage. Recent public comments highlight the risk that European holdings of US stocks and bonds could be drawn into trade disputes, with possible consequences for market stability. The discussion focuses on how cross border investment positions might feature more prominently in future geopolitical negotiations. For Deutsche Bank...
NasdaqGS:NXT
NasdaqGS:NXTElectrical

Nextpower’s New Credit Rating And Saudi JV Refocus Solar Growth Prospects

Fitch Ratings assigns Nextpower (NasdaqGS:NXT) its first investment grade credit rating. Nextpower completes a joint venture with Abunayyan Holding in Saudi Arabia, including a new regional headquarters and advanced manufacturing facility. The new facility is intended to support solar infrastructure build out across the Middle East and North Africa. Nextpower, trading at $100.32, is drawing fresh attention as it pairs a new investment grade rating from Fitch Ratings with a recently...
NasdaqCM:USGO
NasdaqCM:USGOMetals and Mining

A Look At U.S. GoldMining (USGO) Valuation After New Whistler Exploration Targets And 2025 Results

U.S. GoldMining (USGO) has drawn fresh attention after releasing initial 2025 exploration results from its Whistler Project in Alaska, outlining several new high priority gold copper targets across the Whistler Orbit area. See our latest analysis for U.S. GoldMining. The initial 2025 Whistler results have arrived alongside a sharp pick up in market interest, with U.S. GoldMining’s latest share price at $14.20 and a 30 day share price return of 47.61% feeding into a 61.73% year to date share...
NYSE:DG
NYSE:DGConsumer Retailing

How Dollar General’s Rural Same-Day Delivery Expansion At Dollar General (DG) Has Changed Its Investment Story

Dollar General recently expanded its myDG Delivery same-day service to more than 17,000 stores, offering one free delivery per myDG account between January 20 and February 28, 2026, and deepening ties with DoorDash and Uber Eats through its app and website. This push brings app-based same-day delivery to many rural communities that previously had limited access to home delivery, marking a significant step in Dollar General’s broader omnichannel and digital engagement efforts. We’ll now...
SEHK:917
SEHK:917Media

Why Qunabox Group (SEHK:917) Is Up 24.3% After Forecasting a 2025 Swing Back to Profit

Qunabox Group Limited recently issued unaudited earnings guidance for 2025, indicating an expected net profit of RMB 270 million to RMB 330 million, compared with a net loss of RMB 1.66 billion in 2024. The company attributes this turnaround to sustained investment in AI-driven intelligent interaction that has improved operational efficiency and scale, alongside the absence of a very large one-time non-cash fair value loss recorded in 2024. We’ll now examine how this projected return to...
NasdaqGS:ACLX
NasdaqGS:ACLXBiotechs

Arcellx (ACLX) Valuation After FDA Draft Guidance And 2026 Tandem CAR T Data

The recent U.S. FDA draft guidance endorsing minimal residual disease and complete response as endpoints in multiple myeloma, together with new 2026 Tandem Meetings data, has drawn fresh attention to Arcellx (ACLX) and its lead CAR T program. See our latest analysis for Arcellx. After the FDA draft guidance and the new 2026 Tandem Meetings data, Arcellx’s recent 5.66% 1 month share price return stands against an 18.08% 3 month share price decline and a very large 3 year total shareholder...
NasdaqGS:NVAX
NasdaqGS:NVAXBiotechs

Novavax Pfizer Licensing Deal Puts Matrix M And Valuation In Focus

Novavax (NasdaqGS:NVAX) has signed a licensing agreement with Pfizer covering the use of its Matrix-M adjuvant technology in up to two infectious disease areas. The deal includes upfront payments to Novavax, with the potential for future milestone payments and royalties tied to Pfizer’s use of Matrix-M. The agreement signals industry interest in Novavax’s adjuvant platform and introduces new potential revenue channels alongside its own vaccine programs. For you as an investor, this puts...
TSE:8031
TSE:8031Trade Distributors

Is It Too Late To Consider Mitsui (TSE:8031) After Its Strong Multi Year Rally?

If you are wondering whether Mitsui's current share price fairly reflects the business, you are not alone. This article will walk you through what the numbers are really saying about value. Mitsui's share price recently closed at ¥5,133, with returns of 11.6% over 30 days, 8.0% year to date, 73.3% over 1 year, 188.4% over 3 years and a very large gain over 5 years. That naturally raises questions about how much potential or risk is already priced in. Recent coverage has focused on Mitsui's...
NasdaqGM:VCEL
NasdaqGM:VCELBiotechs

Vericel (VCEL) Valuation Check After Updated 2025 Guidance And Profitability Outlook

Updated guidance shifts attention to Vericel Vericel (VCEL) has put out preliminary unaudited guidance for the fourth quarter and full year 2025, flagging 23% revenue growth for the quarter and an expected US$276 million in net revenue for the year. The company also anticipates GAAP net income profitability for a second straight year, a detail many investors watch closely when considering how a commercial stage biotech is converting its product portfolio into earnings. See our latest analysis...
NYSE:ZTS
NYSE:ZTSPharmaceuticals

Zoetis Debuts Lenivia And Portela As OA Safety Story Evolves

Zoetis (NYSE:ZTS) has launched new next generation osteoarthritis treatments, Lenivia and Portela. The products are designed to address safety concerns linked to earlier osteoarthritis pain drugs Librela and Solensia. Both treatments are long acting and require less frequent administration, targeting continuity of care and market share in osteoarthritis pain management. Zoetis, a major animal health company, is expanding its osteoarthritis portfolio with Lenivia and Portela, which aim to...
NasdaqGM:ARRY
NasdaqGM:ARRYElectrical

Array Technologies Jumps As Trade Relief Reshapes Policy Risk Narrative

Array Technologies (NasdaqGM:ARRY) saw renewed investor interest after the US president announced a framework for a future deal with Greenland, easing some global trade tensions. The shift in sentiment is tied to expectations around cross border trade in renewable energy equipment and policy stability. Array’s shares last closed at $10.22 as investors reassessed exposure to companies linked to global solar and clean energy supply chains. Array Technologies comes into this news with a mixed...
NasdaqGS:FHB
NasdaqGS:FHBBanks

First Hawaiian (FHB) Valuation Check After Regional Bank Optimism From Bank Of Hawaii Projections

Recent projections for stronger earnings and revenue at Bank of Hawaii have lifted sentiment across Hawaiian regional banks, and you are now seeing that readthrough show up in First Hawaiian (FHB) as investor interest picks up. See our latest analysis for First Hawaiian. That positive readthrough from Bank of Hawaii comes on top of a steady upswing in First Hawaiian’s own trading, with a 1-day share price return of 4.59% and a 90-day share price return of 17.05%. The 5-year total shareholder...
TSXV:AFM
TSXV:AFMMetals and Mining

A Look At Alphamin Resources (TSXV:AFM) Valuation After Record 2025 Tin Output And New 2026 Growth Guidance

Alphamin Resources (TSXV:AFM) is back in focus after reporting record 2025 tin production of 18,576 tonnes, issuing 2026 guidance of about 20,000 tonnes, and outlining a CEO and CFO transition from March 2026. See our latest analysis for Alphamin Resources. The record 2025 tin output, higher 2026 production guidance and the announced CEO and CFO transition sit alongside a 1 month share price return of 11.67% and a year to date share price return of 15.52%, while the 1 year total shareholder...
OM:SECT B
OM:SECT BHealthcare Services

Assessing Sectra (OM:SECT B) Valuation After New German Hospital Imaging Contract

TUM Klinikum Rechts der Isar’s decision to expand its Sectra (OM:SECT B) enterprise imaging setup with new pathology and ophthalmology modules puts fresh attention on how this five year contract fits into the stock’s current performance. See our latest analysis for Sectra. The TUM Klinikum Rechts der Isar contract lands at a time when Sectra’s share price, now at SEK 224.6, has a 30 day share price return of a 10.87% decline and a 90 day share price return of a 27.45% decline. Meanwhile, the...
NasdaqGS:LGIH
NasdaqGS:LGIHConsumer Durables

LGI Homes Faces Predatory Sales Claims And Potential Regulatory Repercussions

Allegations of systemic predatory sales practices at LGI Homes (NasdaqGS:LGIH) have surfaced, focusing on pressure tactics used on vulnerable homebuyers. The company is accused of providing unlicensed mortgage advice and steering customers toward affiliated lenders, which may conflict with consumer protection rules. Questions are being raised about potential breaches of privacy obligations and how any regulatory response could affect LGI Homes' operations and brand. LGI Homes builds and...